BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21680295)

  • 21. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
    Arabkari V; Clancy E; Dwyer RM; Kerin MJ; Kalinina O; Holian E; Newell J; Smith TJ
    Pathol Oncol Res; 2020 Apr; 26(2):833-844. PubMed ID: 30840191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
    Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
    BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
    Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs as Biomarker for Breast Cancer.
    Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
    Li EW; Bai Y
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33919884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA analysis of NCI-60 human cancer cells indicates that miR-720 and miR-887 are potential therapeutic biomarkers for breast cancer.
    Lv Z; Wang S; Zhao W; He N
    Drug Discov Ther; 2020 Sep; 14(4):197-203. PubMed ID: 32863323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.
    Hannafon BN; Ding WQ
    Am J Pathol; 2019 May; 189(5):966-974. PubMed ID: 30273605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Typical Lung Carcinoids with Metastasis: Potential Role of MicroRNAs in the Regulation of Adaptive Immunity Associated with Disease: a Case Study.
    Seneda AL; Lapa RML; Felix TF; Minutentag IW; Campos CF; Oliveira RA; Oliveira CC; Hasimoto ÉN; Cataneo DC; Cataneo AJM; De Faveri J; Drigo SA; Mur LAJ; Reis PP
    Cell Physiol Biochem; 2021 Jan; 55(S2):1-12. PubMed ID: 33398982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
    McGuire A; Brown JA; Kerin MJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
    Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S
    Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA and cancer chemoprevention.
    Yi B; Piazza GA; Su X; Xi Y
    Cancer Prev Res (Phila); 2013 May; 6(5):401-9. PubMed ID: 23531448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
    Fazi F; Blandino G
    Microrna; 2013; 2(2):81. PubMed ID: 25070777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation sequencing of microRNAs for breast cancer detection.
    Wu Q; Lu Z; Li H; Lu J; Guo L; Ge Q
    J Biomed Biotechnol; 2011; 2011():597145. PubMed ID: 21716661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
    Khan S; Ayub H; Khan T; Wahid F
    Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.